ArticleThe Journal of biological chemistry2026
Altered benzo[a]pyrene adduct formation in nucleosomes establishes distinct mutational patterns in lung cancer.
Article in The Journal of biological chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Benzo[a]pyrene is a carcinogen in tobacco smoke that, when metabolized to benzo[a]pyrene diol epoxide (BPDE), induces mutagenic DNA lesions that promote the development of lung cancer. In lung cells, BPDE damages DNA packaged in nucleosomes, but the impact of nucleosomes on BPDE adduct formation is unclear. Here, we analyze genome-wide maps of BPDE adduct formation and repair in human cells. Our analysis indicates that BPDE adduct formation is suppressed in nucleosomes and enriched in adjacent linker DNA. Within nucleosomes, BPDE adduct formation is specifically elevated at minor-out rotational settings, where the minor groove of the DNA faces outward from the histone octamer. Structural analysis indicates that the solvent accessibility of the reactive exocyclic N2 amino group in guanine bases is elevated at minor-out rotational settings, potentially accounting for elevated BPDE damage at these locations. These damage patterns coincide with and can explain elevated somatic mutation rates in lung cancers at linker DNA and minor-out rotational settings in nucleosomes. While BPDE damage formation in nucleosomes strongly correlates with mutation patterns in lung cancers, the repair of these adducts does not. Analysis of damage patterns at CCCTC-binding factor and SP1 transcription factor binding sites indicates that BPDE damage formation is also suppressed by these DNA-bound proteins, and this damage modulation correlates with mutation patterns at these binding sites in lung cancers. These data indicate that altered BPDE adduct formation in chromatin can explain the distinct patterns of somatic mutations in lung cancers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.